Business activity within the pharma markets is characterized with a complex regulatory environment and global competition between firms and organizations dealing with medical research and development.
The market is also characterized by a continuous development of innovative solutions and long processes for patent registration in target markets. Protecting intellectual property and coping with illegal pharmaceutical activities (private piratic import, counterfeit products) demand knowledge and orientation within complex business processes and complicated technologies.
Meidata produces essential competitive intelligence to pharma companies, which are committed to preserving their leading status within global markets. Our products include:
- Competitive R&D: Monitoring the progress of clinical research and R&D pipelines.
- Strategic Collaborations: Advanced notice on contracts & joined projects between companies & research institutions.
- Regulation Monitoring: Updates concerning legislation, safety procedures and approval processes in countries where products are currently or will be marketed.